Ivim Health
GLP-1 telehealth platform with peer-reviewed clinical outcomes data, offering compounded semaglutide and tirzepatide alongside women's hormone therapy across 49 states.
What we like
What to watch
Full Review
Ivim has built a meaningful position in the telehealth GLP-1 market with 600,000+ registered patients and peer-reviewed clinical data demonstrating above-benchmark weight loss outcomes (21.8% average body weight loss at 68 weeks). The bootstrapped company has scaled without external funding, though its business model carries concentrated risk: revenue depends heavily on compounded semaglutide and tirzepatide, both of which face ongoing FDA and legal challenges. The February 2026 FDA warning letter regarding misleading product labeling adds a trust concern. While the volume of positive Trustpilot reviews and app ratings suggests genuine patient satisfaction, aggressive refund policies and rising BBB complaint volume indicate operational growing pains.
Last researched: 2026-03-30
Pricing
Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.
| Treatment | Category | Price/mo | Includes | Notes |
|---|---|---|---|---|
| Compounded Semaglutide (12-month plan) | Weight Loss / GLP-1 | $150–$175 | ● Consults○ Lab work● Shipping | First month membership free Subscription required |
| Compounded Semaglutide (6-month plan) | Weight Loss / GLP-1 | $175 | ● Consults○ Lab work● Shipping | First month membership free Subscription required |
| Compounded Tirzepatide (12-month plan) | Weight Loss / GLP-1 | $208 | ● Consults○ Lab work● Shipping | First month membership free Subscription required |
| Women's Hormone Optimization | Weight Loss / GLP-1 | $199 | ● Consults○ Lab work● Shipping | Subscription required |